Status:
COMPLETED
Ionized Magnesium for Monitoring of Citrate-anticoagulated CVVHD
Lead Sponsor:
University Hospital, Montpellier
Collaborating Sponsors:
Novamedica Laboratories
Conditions:
Intensive Care Unit Syndrome
Eligibility:
All Genders
18-100 years
Brief Summary
It has been reported in several studies that ionized hypomagnesemia is associated with higher morbidity and mortality rates. During continuous renal replacement therapy with regional citrate anticoagu...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Consecutive patients admitted to the ICU and requiring continuous renal replacement therapy with regional citrate anticoagulation
- age \> 18 ans
- Exclusion criteria:
- Persons under protection
- Paritcipation rejections
Exclusion
Key Trial Info
Start Date :
May 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
November 23 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04412980
Start Date
May 1 2020
End Date
November 23 2020
Last Update
November 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Uhmontpellier
Montpellier, France, 34295